首页 | 本学科首页   官方微博 | 高级检索  
检索        


Panitumumab Monotherapy as a Second-line Treatment in Metastasised Colorectal Cancer: A Single Centre Experience
Institution:1. Catharina Hospital Eindhoven, Eindhoven, The Netherlands;2. Amgen BV, Breda, The Netherlands;3. Merck Serono, Darmstadt, Germany;4. St Radboud University Medical Centre, Nijmegen, The Netherlands;1. Department of Orthopedic Surgery, Indiana University School of Medicine, Gary/Northwest;2. SpineTech, Brain and Spine Centers of Southeast Texas, 6025 Metropolitan Drive, Suite 205, Beaumont, TX 77706, USA;3. Chicago Foot and Ankle Deformity Correction Center, 2913 North Commonwealth Avenue, Chicago, IL 60657, USA;4. Reconstructive Foot & Ankle Fellowship Program, Saint Anthony Hospital;5. Department of Pediatrics, Center for Excellence in Limb Lengthening and Reconstruction;6. University of Texas Medical School, Mischer Neuroscience Institute, Houston, TX, USA;7. SpineTech, Brain and Spine Center of Southeast Texas, 111 Vision Park Boulevard, Shenandoah, TX 77384, USA;8. PMSR/RRA, Department of Orthopedics and Rehabilitation (DO&R), Womack Army Medical Center, 2817 Reilly Road, Fort Bragg, NC 28310, USA;1. Department of Radiation Oncology, Hospital of the University of Pennsylvania, United States;2. Department of Radiation Medicine, Oregon Health & Science University, Portland VA Healthcare System, United States
Abstract:
Keywords:Carcinoembryonic antigen  Metastatic colorectal cancer  Monotherapy  Panitumumab  Response
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号